Compare AGIO & ZD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGIO | ZD |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 2013 | 1999 |
| Metric | AGIO | ZD |
|---|---|---|
| Price | $30.98 | $50.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | $46.11 | ★ $63.33 |
| AVG Volume (30 Days) | ★ 1.2M | 451.0K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 17.22 |
| Revenue | $43,011,000.00 | ★ $1,364,028,000.00 |
| Revenue This Year | $227.92 | N/A |
| Revenue Next Year | $96.10 | $0.79 |
| P/E Ratio | ★ N/A | $2.94 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.24 | $22.45 |
| 52 Week High | $46.00 | $60.48 |
| Indicator | AGIO | ZD |
|---|---|---|
| Relative Strength Index (RSI) | 44.24 | 36.40 |
| Support Level | $26.41 | $39.78 |
| Resistance Level | $35.77 | $56.43 |
| Average True Range (ATR) | 1.85 | 2.26 |
| MACD | -0.54 | -0.71 |
| Stochastic Oscillator | 30.47 | 32.17 |
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Ziff Davis Inc is a digital media and internet company operating a portfolio of brands across technology, shopping, gaming and entertainment, health and wellness, connectivity, and cybersecurity. The company has five reportable segments. The Technology & Shopping segment generates revenue from advertising and commerce content. The Gaming & Entertainment segment provides content, subscriptions, and digital storefront services. The Health & Wellness segment offers digital tools and content for health management. The Connectivity segment provides data and analytics solutions for network performance. The Cybersecurity & Martech segment delivers cloud-based software for security and marketing. It generates the majority of its revenue from the Health & Wellness segment.